Literature DB >> 29269528

ALCL: is it now a curable disease?

Pier Luigi Zinzani1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29269528     DOI： 10.1182/blood-2017-10-811083

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Leukemic phase of ALK-negative anaplastic large cell lymphoma in a patient who is on androgenic steroids: A case report.

Authors:  Ganesh Kasinathan
Journal:  Ann Med Surg (Lond)       Date:  2019-11-22

Review 2.  Targeted Approaches to T-Cell Lymphoma.

Authors:  Sean Harrop; Chathuri Abeyakoon; Carrie Van Der Weyden; H Miles Prince
Journal:  J Pers Med       Date:  2021-05-27

3.  Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter.

Authors:  Jing Li; Moinul Haque; Chuquan Shang; Bardes Hassan; Dongzhe Liu; Will Chen; Raymond Lai
Journal:  Curr Issues Mol Biol       Date:  2021-07-02       Impact factor: 2.976
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.